The presence of ITPase deficiency was not statistically associated with a lower hazard ratio (HR) for RBV dose reductions (HR 0.80, 95% CI 0.35–1.71, p = 0.57). The gene discussed is ITPA; the disease is hyperinsulinemic hypoglycemia, familial, 4.